PDSB PDS Biotechnology Corp
Price Chart
Executive Summary
PDS Biotechnology Corp received a Nasdaq notice on June 2, 2026 confirming it has regained compliance with the $1.00 minimum bid price requirement, closing the deficiency matter first disclosed on February 25, 2026. This removes the immediate delisting risk from Nasdaq, a positive administrative outcome for the $64M market cap clinical-stage biotech.
Actionable Insight
The compliance notice removes a key overhang for PDSB, which had a $64M market cap and 89% analyst bullish consensus. Monitor the stock's ability to sustain above $1.00; any subsequent dip below that threshold could trigger a new 180-day cure period. No financial data or guidance was provided in this filing.
Key Facts
- On February 25, 2026, PDSB received a Nasdaq deficiency letter for trading below $1.00 for 30 consecutive business days.
- On June 2, 2026, Nasdaq notified PDSB that it has regained compliance with the minimum bid price requirement and closed the matter.
- The company's common stock continues to trade on The Nasdaq Capital Market under the symbol PDSB.
Financial Impact
No direct financial figures provided; the filing resolves a delisting risk that could have forced a transfer to OTC markets, preserving Nasdaq listing and associated liquidity/premium.
Risk Factors
- Stock could again fall below $1.00, triggering a new deficiency process.
- No operational or financial catalysts were disclosed; the compliance notice does not change the company's clinical-stage risk profile.
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140361-26-023698 |
| Document: 0001140361-26-023698-index-headers.html | 0001140361-26-023698 |
| Document: 0001140361-26-023698.txt | 0001140361-26-023698 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 2, 2026
12d ago
|
8-K
| $1.16 $1.08 | ▼ −6.90% | ▼ −6.20% | $1.05 (−9.48%) |
|
May 13, 2026
4w ago
|
Press Release
| $1.33 $1.43 | ▲ +7.52% | ▲ +6.74% | $1.05 (−21.05%) |
|
May 1, 2026
6w ago
|
8-K
| $0.9810 $1.00 | ▼ −1.94% | ▼ −2.28% | $1.05 (−7.03%) |
|
Apr 27, 2026
6w ago
|
S-3/A
| $0.9300 $1.08 | ▲ +16.13% | ▲ +16.61% | $1.05 (+12.90%) |
|
Apr 24, 2026
7w ago
|
8-K
| $0.9300 $1.08 | ▲ +16.13% | ▲ +16.61% | $1.05 (+12.90%) |
|
Apr 15, 2026
8w ago
|
8-K
| $1.36 $1.28 | ▼ −5.88% | ▼ −6.14% | $1.05 (−22.79%) |
|
Apr 15, 2026
8w ago
|
Press Release
| $1.36 $1.28 | ▼ −5.88% | ▼ −6.14% | $1.05 (−22.79%) |
|
Mar 30, 2026
10w ago
|
Press Release
| $0.5370 $0.6050 | ▲ +12.66% | ▲ +9.77% | $1.05 (+95.53%) |
|
Mar 24, 2026
11w ago
|
Press Release
| $0.6350 $0.6400 | ▲ +0.79% | ▲ +2.56% | $1.05 (+65.35%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access